Eastern Connecticut Hematology and Oncology Associates — Norwich, Connecticut

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Norwich →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Eastern Connecticut Hematology and Oncology Associates, compiled from the ClinicalTrials.gov public registry.

103

Registered studies

32

Active

6

Recruiting now

52

Completed

10

Stopped or withdrawn

Most-studied conditions

Stage IIIA Lung Non-Small Cell Cancer AJCC v7 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Melanoma · Stage IV Cutaneous Melanoma AJCC v6 and v7

Recently updated registry entries

NCT00265850 — Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients… (Completed)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.